http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014365665-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b58f981963f6d55d627139e778c4ef7b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965
filingDate 2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f3095eceb25f98cee2717d94fea9279
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c4497b434aa7d221c4c7ef5b126d1c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d97c151e04e4008372c59cb663b3dd9d
publicationDate 2019-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2014365665-B2
titleOfInvention Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functional pathological conditions
abstract The present invention relates to the use of PAR1 antagonists, in particular of vorapaxar, of atopaxar and of 3‑(2-chlorophenyl)-1-[4-(4-fluorobenzyl)piperazin-1-yl]propenone, or a pharmaceutically acceptable salt thereof, for preventing and/or treating pelvi-perineal functional pathological conditions, and more particularly painful bladder syndrome.
priorityDate 2013-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2902426-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449367877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36511
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6863
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419905441
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448848571
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID55010
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37720
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415712569
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24806
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590747
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID819276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415721994
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21333
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID535197
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100277053
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID820085
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591501
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID60328
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281512
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10077130
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122587899
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10459564
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID734977
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13728

Total number of triples: 80.